ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1403 • ACR Convergence 2022

    Herpes Zoster in Rheumatoid Arthritis: Prospective Single University Center Study

    Lucia Cristina Dominguez Casas1, Mª Paz Rodriguez Cundin2, Trinidad Dierssen Sotos3, Nuria Vegas Revenga4, Alfonso Corrales5, Miguel Ángel González-Gay6 and Ricardo Blanco7, 1Hospital Universtario San Agustin, Oviedo, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Universidad de Cantabria, Santander, Spain, 4Hospital Galdakao- Usansolo, Galdakao, Spain, 5Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 6Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 7Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Patients with Rheumatoid arthritis (RA) have an increased risk of infections due to the disease itself, and/or immunosuppressive therapy. The risk of herpes zoster…
  • Abstract Number: 1388 • ACR Convergence 2022

    Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10 Diagnostic Codes

    Anthony Dolomisiewicz1, Hanifah Ali2, Punyasha Roul3, Yangyuna Yang1, Grant Cannon4, Joshua Baker5, Ted Mikuls6, Kaleb Michaud1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, 3UNMC, Omaha, NE, 4Salt Lake City VA, Salt Lake city, 5University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 6Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The Rheumatic Disease Comorbidity Index (RDCI) was designed to quantify comorbidity burden for risk stratification of health outcomes in patients with rheumatic disease. Developed…
  • Abstract Number: 1402 • ACR Convergence 2022

    Late Onset Rheumatoid Arthritis Has a Similar Remission Rate as Younger Onset Rheumatoid Arthritis: Results from an Ontario Rheumatoid Arthritis Registry

    Xiuying Li1, Angela Cesta1, Mohammad Movahedi2 and Claire Bombardier3, 1University Health Network, Toronto, ON, Canada, 2Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada

    Background/Purpose: The prevalence of rheumatoid arthritis (RA) in persons 60 years or older is estimated to be 2%. Late onset rheumatoid arthritis (LORA) is a…
  • Abstract Number: 1401 • ACR Convergence 2022

    Relationship Between Disease Activity and Adverse Events of Interest in Patients with RA on Tofacitinib or TNF Inhibitors: Post Hoc Analysis of a Phase 3b/4 Randomized Safety Study

    George A Karpouzas1, Zoltan Szekanecz2, Eva Baecklund3, Ted Mikuls4, Deepak L Bhatt5, Harry Shi6, Cunshan Wang7, Gosford A Sawyerr8, Yan Chen6, Sujatha Menon7, Carol A Connell7, Steven R Ytterberg9 and Mahta Mortezavi8, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Division of Rheumatology, Faculty of Medicine, Debrecen, Hungary, 3Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 4Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 5Department of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 6Pfizer, Inc, Collegeville, PA, 7Pfizer Inc, Groton, CT, 8Pfizer Inc, New York, NY, 9Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Uncontrolled RA activity and acute disease flares are associated with higher risk of adverse outcomes, such as cardiovascular (CV) disease, venous thromboembolism (VTE), malignancy,…
  • Abstract Number: 1397 • ACR Convergence 2022

    The Impact of Disease Activity on Patient-Reported Cognitive Dysfunction in Rheumatoid Arthritis

    Ozlem Pala1, Dimitrios Pappas2, George Reed3 and Joel Kremer4, 1University of Miami, Fort Lauderdale, FL, 2Corrona Research Foundation; CorEvitas, LLC, Albany, NY, 3University of Massachusetts Medical School, Worcester, MA, 4The Corrona Research Foundation, Delray Beach, FL

    Background/Purpose: Rheumatoid Arthritis (RA) is a systemic, inflammatory disease, and its burden extends beyond joint disease. RA is not commonly associated with central nervous system…
  • Abstract Number: 1348 • ACR Convergence 2022

    We Asked Patients and Families: What Is the Job of a Pediatric Rheumatologist?

    Emily Hause1, Nathan Rubin2, Bryce Binstadt1, Colleen Correll1, Patricia Hobday1, Alison Lerman1, Shawn Mahmud1, Mona Riskalla1, Meghan Ryan3, Zachary Shaheen1 and Danielle Bullock1, 1University of Minnesota, Minneapolis, MN, 2University of Minnesota Masonic Cancer Center, Minneapolis, MN, 3University of Minnesota, Vadnais Heights, MN

    Background/Purpose: Pediatric rheumatology is a highly specialized field, with approximately 300 practicing pediatric rheumatologists in the United States. Prior research into patient understanding of medical…
  • Abstract Number: 1380 • ACR Convergence 2022

    Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus

    Rebecca Sadun1, Laura Lewandowski2, Alexandre Belot3, Eve Smith4 and Jennifer Cooper5, 1Duke University, Durham, NC, 2NIAMS, NIH, Bethesda, MD, 3Hospices Civils de Lyon, Collonges au mont d'or, France, 4University of Liverpool, Liverpool, United Kingdom, 5University of Colorado/Children's Hospital Colorado, Denver, CO

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) occurs in approximately 20% of all SLE cases. cSLE is has a worse prognosis than adult-onset SLE, often requiring…
  • Abstract Number: 1393 • ACR Convergence 2022

    Lung Involvement in Early Rheumatoid Arthritis, Interim Analysis of the FINDRA Prospective Study

    Marie Doyen1, Marie Perrot2, Benoit Ghaye3, Emilie Sapart1, Deniz Zan3, Aleksandra avramovska1, Tatiana Sokolova4, maria stoenoiu1, sandra koenig2, antoine froidure2 and Patrick Durez5, 1Rheumatology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 2Pulmonology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 3Radiology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 4Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium, 5Institute de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint-Luc - Université Catholique de Louvain (UCL), Brussels, Belgium

    Background/Purpose: The prevalence of lung involvement in rheumatoid arthritis (RA) remains elusive. We set up a prospective study to detect ILD, bronchiolitis and nodules in…
  • Abstract Number: 1295 • ACR Convergence 2022

    Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice

    Tara Skorupa1, Kristin Sturm2, Aaron Lazorwitz2, Guiset Carvajal Bedoya3, Ju Young Kwag2, JoAnn Zell2 and Kristen Demoruelle2, 1University of Colorado, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3Billings Clinic, Billings, MT

    Background/Purpose: Systemic autoimmune diseases disproportionately affect females of childbearing potential. Many of the medications used to treat systemic autoimmune diseases have suspected or confirmed teratogenic…
  • Abstract Number: 1357 • ACR Convergence 2022

    The ANCA-Associated Vasculitis Patient-Reported Outcome (AAV-PRO) Captures Depression and Health-Related Quality of Life More Than Disease Activity and Damage

    Annika Maunz1, Joerg Henes2, Joanna Robson3, Johann Jacoby4, Bernhard Hellmich5 and Christian Löffler6, 1Medius Kliniken - Teaching Hospital University of Tübingen, Kirchheim-Teck, Tübingen, Germany, 2Center for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases (INDIRA), University Hospital Tübingen, Tübingen, Germany, 3UWE Bristol, Bristol, United Kingdom, 4University Hospital Tübingen, Institute for Clinical Epidemiology and Applied Biometry, Tübingen, Germany, 5Klinik für Innere Medizin, Rheumatologie & Immunologie, Medius Kliniken, Universität Tübingen, Plochingen, Germany, 6Medius Kliniken - Teaching Hospital University of Tübingen,, Kirchheim Teck, Germany

    Background/Purpose: The ANCA-associated vasculitis patient-reported outcome (AAV-PRO) is a new disease-specific PRO developed to capture the impact of having AAV and dealing with its treatment…
  • Abstract Number: 1404 • ACR Convergence 2022

    Machine Learning Model to Accurately Identify Rheumatoid Arthritis Patients Using Raw Electronic Health Record Data

    Vinit Gilvaz1, Anthony Reginato2, Deepan Dalal3 and Brad Crough4, 1Brown University, East Providence, RI, 2Brown University, Providence, RI, 3Brown University School of Medicine, Providence, RI, 4Brown Physicians Inc., Providence, RI

    Background/Purpose: Patients with chronic medical conditions like rheumatoid arthritis (RA) have a wealth of clinical data stored within their electronic medical records (EMR). Artificial intelligence…
  • Abstract Number: 1389 • ACR Convergence 2022

    The New Serum Synovial Biochemical Marker HELIX-III Predicts Radiological Progression in Early Arthritis Independently of Usual Risk Factors

    Patrick Garnero1, Evelyne Gineyts1, Jean-Charles Rousseau1, Pascal Richette2, Jérémie SELLAM3 and Roland Chapurlat1, 1INSERM 1033, Lyon, France, 2Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 3Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France

    Background/Purpose: The prognosis of rheumatoid arthritis (RA) is highly variable across patients (P.) and difficult to predict. Usual risk factors, e.g., radiological joint damage, increased…
  • Abstract Number: 1284 • ACR Convergence 2022

    Comparative Effectiveness Randomized Controlled Trials in Rheumatology Guidelines

    Kathryn Henry1, Desh Nepal2, Erin Valley2, Connor Pedersen2, Ali Duarte-Garcia3 and Mike Putman4, 1Medical College of Wisconsin, Manitowoc, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3Mayo Clinic, Rochester, MN, 4The Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Comparative effectiveness randomized controlled trials (RCTs) compare two active interventions in a head-to-head design. They are useful for informing clinical practice guidelines, but the…
  • Abstract Number: 1400 • ACR Convergence 2022

    Machine Learning Identifies Molecular Phenotypes That Predict Incident Cardiovascular Disease in Patients with Rheumatoid Arthritis

    Tate Johnson1, Rebekah Gundry2, Merry Lindsey2, Punyasha Roul3, Yangyuna Yang2, Joshua Baker4, Brian Sauer5, Grant Cannon6, Geoffrey Thiele2, Ted Mikuls7 and Bryant England2, 1University of Nebraska Medical Center, Elkhorn, NE, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6Retired, Salt Lake City, UT, 7Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Cardiovascular disease (CVD) remains the leading cause of death in patients with rheumatoid arthritis (RA). General population CVD risk calculators underestimate risk in RA,…
  • Abstract Number: 1368 • ACR Convergence 2022

    How Common Is the Coexistence of Juvenile Localized and Systemic Scleroderma? Results of a Multination Survey

    Ivan Foeldvari1, Nicola Helmus2 and Suzanne Li3, 1Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 2Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany, 3Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, West Orange, NJ

    Background/Purpose: Pediatric scleroderma consists of two diseases, juvenile localized scleroderma (jLS) and juvenile systemic sclerosis (jSSc). While jLS and jSSc share some disease processes, there…
  • « Previous Page
  • 1
  • …
  • 376
  • 377
  • 378
  • 379
  • 380
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology